Exposure reconstruction for reducing uncertainty in risk assessment: example using MTBE biomarkers and a simple pharmacokinetic model

被引:30
作者
Pleil, J. D. [1 ]
Kim, D.
Prah, J. D.
Rappaport, S. M.
机构
[1] US EPA, Human Exposure & Atmospher Sci Div, Natl Exposure Res Lab, Off Res & Dev, Res Triangle Pk, NC USA
[2] Univ N Carolina, Sch Publ Hlth, Dept Environm Sci & Engn, Chapel Hill, NC 27599 USA
[3] Harvard Univ, Sch Publ Hlth, Dept Environm Hlth, Boston, MA USA
关键词
environmental health risk; classical pharmacokinetic model; exhaled breath sample; blood sample; exposure assessment; exposure reconstruction; VOLATILE ORGANIC-COMPOUNDS; TERTIARY BUTYL ETHER; EXHALED BREATH; VARIABILITY; METABOLISM; HUMANS; TOXICOKINETICS;
D O I
10.1080/13547500701246334
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Adverse health risks from environmental agents are generally related to average (long-term) exposures. Because a given individual's contact with a pollutant is highly variable and dependent on activity patterns, local sources and exposure pathways, simple 'snapshot' measurements of surrounding environmental media may not accurately assign the exposure level. Furthermore, susceptibility to adverse effects from contaminants is considered highly variable in the population so that even similar environmental exposure levels may result in differential health outcomes in different individuals. The use of biomarker measurements coupled to knowledge of rates of uptake, metabolism and elimination has been suggested as a remedy for reducing this type of uncertainty. To demonstrate the utility of such an approach, we invoke results from a series of controlled human exposure tests and classical first-order rate kinetic calculations to estimate how well spot measurements of methyl tertiary butyl ether and the primary metabolite, tertiary butyl alcohol, can be expected to predict different hypothetical scenarios of previous exposures. We found that blood and breath biomarker measurements give similar results and that the biological damping effect of the metabolite production gives more stable estimates of previous exposure. We also explore the value of a potential urinary biomarker, 2-hydroxyisobutyrate suggested in the literature. We find that individual biomarker measurements are a valuable tool in reconstruction of previous exposures and that a simple pharmacokinetic model can identify the time frames over which an exogenous chemical and the related chemical biomarker are useful. These techniques could be applied to broader ranges of environmental contaminants to assess cumulative exposure risks if ADME (Absorption, Distribution, Metabolization and Excretion) is understood and systemic biomarkers can be measured.
引用
收藏
页码:331 / 348
页数:18
相关论文
共 36 条
[1]   Biotransformation and kinetics of excretion of methyl-tert-butyl ether in rats and humans [J].
Amberg, A ;
Rosner, E ;
Dekant, W .
TOXICOLOGICAL SCIENCES, 1999, 51 (01) :1-8
[2]   Toxicokinetics of methyl tert-butyl ether and its metabolites in humans after oval exposure [J].
Amberg, A ;
Rosner, E ;
Dekant, W .
TOXICOLOGICAL SCIENCES, 2001, 61 (01) :62-67
[3]   DETERMINING VOLATILE ORGANIC-COMPOUNDS IN HUMAN BLOOD FROM A LARGE SAMPLE-POPULATION BY USING PURGE AND TRAP GAS-CHROMATOGRAPHY MASS-SPECTROMETRY [J].
ASHLEY, DL ;
BONIN, MA ;
CARDINALI, FL ;
MCCRAW, JM ;
HOLLER, JS ;
NEEDHAM, LL ;
PATTERSON, DG .
ANALYTICAL CHEMISTRY, 1992, 64 (09) :1021-1029
[4]  
BOROUJERDI M., 2002, Pharmacokinetics: Principles and Applications
[5]   Body burden measurements and models to assess inhalation exposure to methyl tertiary butyl ether (MTBE) [J].
Buckley, TJ ;
Prah, JD ;
Ashley, D ;
Zweidinger, RA ;
Wallace, LA .
JOURNAL OF THE AIR & WASTE MANAGEMENT ASSOCIATION, 1997, 47 (07) :739-752
[6]  
*CALEPA, 1998, DRAFT PUBL HLTH GOAL
[7]  
*CARB, 1997, TOX AIR CONT ID LIST
[8]   Metabolism and bioactivation of toxicants in the lung.: The in vitro cellular approach [J].
Castell, JV ;
Donato, MT ;
Gómez-Lechón, MJ .
EXPERIMENTAL AND TOXICOLOGIC PATHOLOGY, 2005, 57 :189-204
[9]   Evaluation of physiologically based pharmacokinetic models in risk assessment: An example with perchloroethylene [J].
Clewell, HJ ;
Gentry, PR ;
Kester, JE ;
Andersen, ME .
CRITICAL REVIEWS IN TOXICOLOGY, 2005, 35 (05) :413-433
[10]  
*CRS, 2001, MTBE GAS CLEAN AIR D